Clinical Trial

Screening for AL Amyloidosis in Smoldering Multiple Myeloma

Recruiting
View on ClinicalTrials.gov →
Summary
In this multicenter study, we will recruit 400 patients 40 years of age or older at 15 centers with a diagnosis of smoldering multiple myeloma (SMM), a group of patients for whom standard of care is observation not treatment. The main goal of this study is to screen for the diagnosis of light-chain amyloidosis (AL) before the onset of symptomatic disease and to develop a training set for a likelihood algorithm.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-04-10; most recent amendment 2025-08-01.
Status change: Not Yet Recruiting → Recruiting 2024-07-18
Trial Details
NCT Number NCT06365060
Lead Sponsor Tufts Medical Center
Collaborators: National Cancer Institute (NCI)
Conditions Smoldering Multiple Myeloma
Enrollment 400 participants
Start Date 2024-05-01
Primary Completion 2029-02-27 (estimated)
Study Completion 2029-02-27 (estimated)
Updated on ClinicalTrials.gov 2025-08-06